Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

The discovery of novel 3-aryl-indazole derivatives as peripherally restricted pan-Trk inhibitors for the treatment of pain.

Shirahashi H, Toriihara E, Suenaga Y, Yoshida H, Akaogi K, Endou Y, Wakabayashi M, Takashima M.

Bioorg Med Chem Lett. 2019 Aug 15;29(16):2320-2326. doi: 10.1016/j.bmcl.2019.06.018. Epub 2019 Jun 17.

PMID:
31235262
2.

[A Case of Rectal Cancer Presenting with Perianal Abscess].

Machida T, Ohta S, Kakimoto Y, Toyoda A, Endou Y, Murakami O.

Gan To Kagaku Ryoho. 2019 Jan;46(1):88-90. Japanese.

PMID:
30765650
3.

Repeated Combined Chemotherapy with Cisplatin Lowers Carnitine Levels in Gastric Cancer Patients.

Kawai A, Matsumoto H, Endou Y, Honda Y, Kubota H, Higashida M, Hirai T.

Ann Nutr Metab. 2017;71(3-4):261-265. doi: 10.1159/000485808. Epub 2017 Dec 13.

4.

5-Aminolevulinic Acid Fluorescence in Detection of Peritoneal Metastases.

Yonemura Y, Canbay E, Ishibashi H, Nishino E, Endou Y, Sako S, Ogura S.

Asian Pac J Cancer Prev. 2016;17(4):2271-5.

5.

[Antimicrobial Susceptibility of Streptococcus pneumoniae Isolated from 8 Hospitals in Chiba Prefecture Following the Introduction of 7-valent Pneumococcal Conjugate Vaccine].

Shizuno K, Takahashi H, Murata S, Endou Y, Maruyama H, Otsuka Y, Akiba Y, Suzuki S, Kurosaki T, Kanno H.

Kansenshogaku Zasshi. 2015 Jul;89(4):437-44. Japanese.

PMID:
26554218
6.

Significance of caveolin-1 and matrix metalloproteinase 14 gene expression in canine mammary tumours.

Ebisawa M, Iwano H, Nishikawa M, Tochigi Y, Komatsu T, Endou Y, Hirayama K, Taniyama H, Kadosawa T, Yokota H.

Vet J. 2015 Nov;206(2):191-6. doi: 10.1016/j.tvjl.2015.07.020. Epub 2015 Jul 23.

PMID:
26364240
7.

Peritoneal cancer treatment.

Yonemura Y, Canbay E, Endou Y, Ishibashi H, Mizumoto A, Miura M, Li Y, Liu Y, Takeshita K, Ichinose M, Takao N, Hirano M, Sako S, Tsukiyama G.

Expert Opin Pharmacother. 2014 Apr;15(5):623-36. doi: 10.1517/14656566.2014.879571. Review.

PMID:
24617975
8.

Treatment results of diffuse malignant peritoneal mesothelioma.

Yonemura Y, Ishibashi H, Canbay E, Sako S, Tsukiyama G, Mizumoto Y, Ichinose M, Takao N, Yabuki S, Tanaka H, Hirano M, Fushida S, Endou Y.

Gan To Kagaku Ryoho. 2012 Nov;39(12):2416-9.

PMID:
23268096
9.

Effects of neoadjuvant intraperitoneal/systemic chemotherapy (bidirectional chemotherapy) for the treatment of patients with peritoneal metastasis from gastric cancer.

Yonemura Y, Elnemr A, Endou Y, Ishibashi H, Mizumoto A, Miura M, Li Y.

Int J Surg Oncol. 2012;2012:148420. doi: 10.1155/2012/148420. Epub 2012 Jul 31.

10.

Surgical results of patients with peritoneal carcinomatosis treated with cytoreductive surgery using a new technique named aqua dissection.

Yonemura Y, Elnemr A, Endou Y, Ishibashi H, Mizumoto A, Miura M, Li Y.

Gastroenterol Res Pract. 2012;2012:521487. doi: 10.1155/2012/521487. Epub 2012 May 15.

11.

[A case of drug-induced eosinophilic pneumonia due to tegafur-uracil(UFT®)].

Nagahiro I, Miyamoto M, Sugiyama H, Kawai T, Toda K, Nobuhisa T, Endou Y, Watanabe T, Matsumoto Y, Watanabe N, Kai K, Satou S.

Gan To Kagaku Ryoho. 2011 Oct;38(10):1679-82. Review. Japanese.

PMID:
21996966
12.

Indication of peritonectomy for peritoneal dissemination.

Yonemura Y, Tsukiyama G, Miyata R, Sako S, Endou Y, Hirano M, Mizumoto A, Matsuda T, Takao N, Ichinose M, Miura M, Hagiwara A, Li Y.

Gan To Kagaku Ryoho. 2010 Nov;37(12):2306-11.

PMID:
21224556
13.

Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer.

Yonemura Y, Elnemr A, Endou Y, Hirano M, Mizumoto A, Takao N, Ichinose M, Miura M, Li Y.

World J Gastrointest Oncol. 2010 Feb 15;2(2):85-97. doi: 10.4251/wjgo.v2.i2.85.

14.

Surgical treatment for peritoneal carcinomatosis from gastric cancer.

Yonemura Y, Endou Y, Sasaki T, Hirano M, Mizumoto A, Matsuda T, Takao N, Ichinose M, Miura M, Li Y.

Eur J Surg Oncol. 2010 Dec;36(12):1131-8. doi: 10.1016/j.ejso.2010.09.006. Epub 2010 Oct 8. Review.

PMID:
20933363
15.

Delayed enhancement cardiac magnetic resonance imaging in propionic acidemia.

Iwashima S, Ishikawa T, Ohzeki T, Endou Y.

Pediatr Cardiol. 2010 Aug;31(6):884-6. doi: 10.1007/s00246-010-9723-8. Epub 2010 May 19.

PMID:
20490478
16.

[Pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma accompanied with cystic change].

Nagahiro I, Nouso H, Kawai T, Toda K, Nobuhisa T, Endou Y, Watanabe T, Matsumoto Y, Kai K, Ishizuka S, Satou S.

Kyobu Geka. 2010 Apr;63(4):332-5. Japanese.

PMID:
20387510
17.

Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery.

Yonemura Y, Endou Y, Shinbo M, Sasaki T, Hirano M, Mizumoto A, Matsuda T, Takao N, Ichinose M, Mizuno M, Miura M, Ikeda M, Ikeda S, Nakajima G, Yonemura J, Yuuba T, Masuda S, Kimura H, Matsuki N.

J Surg Oncol. 2009 Sep 15;100(4):311-6. doi: 10.1002/jso.21324.

PMID:
19697437
18.

[Resected case of pulmonary arteriovenous malformation diagnosed with a brain abscess as a clinical manifestation; report of a case].

Yoshida K, Nagahiro I, Endou Y, Satou S, Nakashima A.

Kyobu Geka. 2008 Mar;61(3):246-9. Japanese.

PMID:
18323194
19.

[Long-term results of peritonectomy on the patients with peritoneal carcinomatosis].

Yonemura Y, Ikeno T, Shinbo M, Maejima S, Hagiwara A, Endou Y, Masahiro M, Ogura S; Peritoneal Surface Malignancy; Treatment Group.

Gan To Kagaku Ryoho. 2007 Nov;34(12):1926-30. Japanese.

PMID:
18219855
20.

Advances in the management of gastric cancer with peritoneal dissemination.

Yonemura Y, Kawamura T, Bandou E, Tsukiyama G, Nemoto M, Endou Y, Miura M.

Recent Results Cancer Res. 2007;169:157-64. No abstract available.

PMID:
17506258
21.

The natural history of free cancer cells in the peritoneal cavity.

Yonemura Y, Kawamura T, Bandou E, Tsukiyama G, Endou Y, Miura M.

Recent Results Cancer Res. 2007;169:11-23. No abstract available.

PMID:
17506246
22.

Evaluation of lymphatic invasion in primary gastric cancer by a new monoclonal antibody, D2-40.

Yonemura Y, Endou Y, Tabachi K, Kawamura T, Yun HY, Kameya T, Hayashi I, Bandou E, Sasaki T, Miura M.

Hum Pathol. 2006 Sep;37(9):1193-9. Epub 2006 Jul 20.

PMID:
16938525
23.

[A case report: an ileus caused by cecal volvulus and intersigmoidal hernia due to mesenterium commune].

Ikeuchi K, Torii A, Kurita A, Yamashita Y, Aihara K, Matsubara S, Hamada A, Endou Y, Takeda Y, Yamakawa M, Nisikawa A, Noguchi M.

Nihon Shokakibyo Gakkai Zasshi. 2006 Apr;103(4):415-9. Japanese.

PMID:
16629460
24.

Neoadjuvant treatment of gastric cancer with peritoneal dissemination.

Yonemura Y, Bandou E, Sawa T, Yoshimitsu Y, Endou Y, Sasaki T, Sugarbaker PH.

Eur J Surg Oncol. 2006 Aug;32(6):661-5. Epub 2006 Apr 18.

PMID:
16621433
25.

Quantitative prognostic indicators of peritoneal dissemination of gastric cancer.

Yonemura Y, Bandou E, Kawamura T, Endou Y, Sasaki T.

Eur J Surg Oncol. 2006 Aug;32(6):602-6. Epub 2006 Apr 17. Review.

PMID:
16617004
26.

[Effect of intraperitoneal chemotherapy on experimental peritoneal dissemination of gastric cancer].

Yonemura Y, Endou Y, Tochiori S, Bando E, Kawamura T, Shimada T, Miyamoto K, Tanaka M, Sasaki T.

Gan To Kagaku Ryoho. 2005 Oct;32(11):1635-9. Japanese.

PMID:
16315893
27.

[An autopsy case with cerebral histoplasmoma: case report].

Arai T, Fujigasaki J, Arakawa H, Nagashima H, Joki T, Murakami S, Endou Y, Fukada T, Sugita T, Abe T.

No To Shinkei. 2004 Sep;56(9):795-800. Japanese.

PMID:
15552870
28.

Effect of intraperitoneal administration of docetaxel on peritoneal dissemination of gastric cancer.

Yonemura Y, Endou Y, Bando E, Kuno K, Kawamura T, Kimura M, Shimada T, Miyamoto K, Sasaki T, Sugarbaker PH.

Cancer Lett. 2004 Jul 16;210(2):189-96.

PMID:
15183534
29.

Effective therapy for peritoneal dissemination in gastric cancer.

Yonemura Y, Bandou E, Kinoshita K, Kawamura T, Takahashi S, Endou Y, Sasaki T.

Surg Oncol Clin N Am. 2003 Jul;12(3):635-48. Review.

PMID:
14567022
30.

REG gene expression is associated with the infiltrating growth of gastric carcinoma.

Yonemura Y, Sakurai S, Yamamoto H, Endou Y, Kawamura T, Bandou E, Elnemr A, Sugiyama K, Sasaki T, Akiyama T, Takasawa S, Okamoto H.

Cancer. 2003 Oct 1;98(7):1394-400.

31.

Expression of collagenase-3 (matrix metalloproteinase-13) in human gastric cancer.

Elnemr A, Yonemura Y, Bandou E, Kinoshita K, Kawamura T, Takahashi S, Tochiori S, Endou Y, Sasaki T.

Gastric Cancer. 2003;6(1):30-8.

PMID:
12673424
32.

Role of MMP-7 in the formation of peritoneal dissemination in gastric cancer.

Yonemura Y, Endou Y, Fujita H, Fushida S, Bandou E, Taniguchi K, Miwa K, Sugiyama K, Sasaki T.

Gastric Cancer. 2000 Sep 29;3(2):63-70.

PMID:
11984713
33.

Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study.

Yonemura Y, de Aretxabala X, Fujimura T, Fushida S, Katayama K, Bandou E, Sugiyama K, Kawamura T, Kinoshita K, Endou Y, Sasaki T.

Hepatogastroenterology. 2001 Nov-Dec;48(42):1776-82.

PMID:
11813623
34.

Diagnostic value of preoperative RT-PCR-based screening method to detect carcinoembryonic antigen-expressing free cancer cells in the peritoneal cavity from patients with gastric cancer.

Yonemura Y, Endou Y, Fujimura T, Fushida S, Bandou E, Kinoshita K, Sugiyama K, Sawa T, Kim BS, Sasaki T.

ANZ J Surg. 2001 Sep;71(9):521-8.

PMID:
11527261
35.

Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer.

Yonemura Y, Endou Y, Kimura K, Fushida S, Bandou E, Taniguchi K, Kinoshita K, Ninomiya I, Sugiyama K, Heizmann CW, Schafer BW, Sasaki T.

Clin Cancer Res. 2000 Nov;6(11):4234-42.

36.

[Molecular mechanisms of peritoneal dissemination].

Yonemura Y, Endou Y.

Nihon Shokakibyo Gakkai Zasshi. 2000 Jun;97(6):680-90. Review. Japanese. No abstract available.

PMID:
10879079
37.

A new surgical approach (peritonectomy) for the treatment of peritoneal dissemination.

Yonemura Y, Fujimura T, Fushida S, Fujita H, Bando E, Nishimura G, Miwa K, Endou Y, Tanaka M, Sasaki T.

Hepatogastroenterology. 1999 Jan-Feb;46(25):601-9.

PMID:
10228868
38.

Carcinosarcoma of the esophagus with metastases showing osteosarcoma: a case report and review of the literature.

Kinoshita Y, Tsurumaru M, Udagawa H, Kajiyama Y, Tsutsumi K, Ueno M, Nakamura T, Akiyama H, Takagawa R, Endou Y.

Dis Esophagus. 1998 Jul;11(3):189-93. Review.

PMID:
9844802
39.

Immunohistochemical study of MT-MMP tissue status in gastric carcinoma and correlation with survival analyzed by univariate and multivariate analysis.

Bando E, Yonemura Y, Endou Y, Sasaki T, Taniguchi K, Fujita H, Fushida S, Fujimura T, Nishimura G, Miwa K, Seiki M.

Oncol Rep. 1998 Nov-Dec;5(6):1483-8.

PMID:
9769392
40.

[A fatal case of aggressive-phase multiple myeloma with ileus and invasion into extramedullary organs].

Takaya N, Miyakoshi S, Kubo K, Mutou Y, Endou Y.

Rinsho Ketsueki. 1998 May;39(5):379-85. Review. Japanese.

PMID:
9637889
41.

Prognostic significance of c-erbB-2 gene expression in the poorly differentiated type of adenocarcinoma of the stomach.

Yonemura Y, Ninomiya I, Tsugawa K, Fushida S, Fujimura T, Miyazaki I, Uchibayashi T, Endou Y, Sasaki T.

Cancer Detect Prev. 1998;22(2):139-46.

PMID:
9544434
42.

Association of progression and reduced expression of VLA-2 in gastric cancer.

Ajisaka H, Yonemura Y, Fujita H, Michiwa Y, Kawamura T, Satou T, Nojima N, Fushida S, Fujimura T, Miwa K, Endou Y, Sasaki T.

Oncol Rep. 1997 Nov-Dec;4(6):1265-9.

PMID:
21590234
43.

Correlation between expression of urokinase-type plasminogen activator receptor and metastasis in gastric carcinoma.

Yonemura Y, Nojima N, Kawamura T, Ajisaka H, Taniguchi K, Fujimura T, Fujita H, Bandou E, Fushida S, Endou Y, Obata T, Sasaki T.

Oncol Rep. 1997 Nov-Dec;4(6):1229-34.

PMID:
21590227
44.

A possible role of cytokines in the formation of peritoneal dissemination.

Yonemura Y, Endou Y, Nojima M, Kawamura T, Fujita H, Kaji M, Ajisaka H, Bandou E, Sasaki T, Yamaguchi T, Harada S, Yamamoto H.

Int J Oncol. 1997 Aug;11(2):349-58.

PMID:
21528221
45.

E-cadherin and c-met expression as a prognostic factor in gastric cancer.

Yonemura Y, Nojima N, Kaji M, Kawamura T, Fushida S, Fujimura T, Itoh H, Fujita H, Miyazaki J, Endou Y, Sasaki T, Yamamoto H.

Oncol Rep. 1997 Jul-Aug;4(4):743-8.

PMID:
21590132
46.

Correlation of peritoneal dissemination and integrin alpha 3 expression in gastric cancer.

Yonemura Y, Taniguchi K, Nojima N, Fujimura T, Kawamura T, Fujita H, Ajisaka H, Fushida S, Miyazaki I, Endou Y, Sasaki T.

Oncol Rep. 1997 May-Jun;4(3):549-55.

PMID:
21590096
47.

Roles of VLA-2 and VLA-3 on the formation of peritoneal dissemination in gastric cancer.

Yonemura Y, Endou Y, Yamaguchi T, Nojima N, Kawamura T, Fujimura T, Obata T, Kim B, Miyazaki I, Sasaki T.

Int J Oncol. 1996 May;8(5):925-31.

PMID:
21544447
48.

Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination.

Yonemura Y, Fujimura T, Nishimura G, FallaR, Sawa T, Katayama K, Tsugawa K, Fushida S, Miyazaki I, Tanaka M, Endou Y, Sasaki T.

Surgery. 1996 Apr;119(4):437-44.

PMID:
8644010
49.

Amplification of epidermal growth factor receptor gene and its relationship to survival in human gastric cancer.

Hirono Y, Tsugawa K, Fushida S, Ninomiya I, Yonemura Y, Miyazaki I, Endou Y, Tanaka M, Sasaki T.

Oncology. 1995 May-Jun;52(3):182-8.

PMID:
7715901
50.

Decreased E-cadherin expression correlates with poor survival in patients with gastric cancer.

Yonemura Y, Ninomiya I, Kaji M, Sugiyama K, Fujimura T, Tsuchihara K, Kawamura T, Miyazaki I, Endou Y, Tanaka M, et al.

Anal Cell Pathol. 1995 Mar;8(2):177-90.

PMID:
7786814

Supplemental Content

Support Center